This applies only to T-cell leukemia and lymphoma, and probably also to some nonhematopoietic tumors, that express high levels of BCL11B. Those malignant cells are dependent on DNA repair provided by BCL11B, and deprived of this would eventually undergo cell senescence and die. The gene discussed is BCL11B; the disease is T-cell leukemia.